Stay updated on Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page remains a 403 Forbidden error page, while the footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:34:40.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous detailed study content and sections.
    Difference
    21%
    Check dated 2026-09-21T20:40:06.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces the previous v3.6.5 on the page, indicating a small update to the documentation. It does not alter study content or page functionality.
    Difference
    0.0%
    Check dated 2026-08-31T18:21:11.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now includes an additional funding identifier indicating a U.S. NIH grant/contract for the study in 2016.
    Difference
    0.0%
    Check dated 2026-08-24T19:15:48.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, indicating a minor patch to the page's documentation. This does not reflect a substantive change to content or features.
    Difference
    0.0%
    Check dated 2026-08-10T12:54:35.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page updated its revision label from v3.6.3 to v3.6.4, reflecting a new build/version in the site metadata. This change represents a minor update to the page's underlying versioning information rather than any user-facing content.
    Difference
    0.0%
    Check dated 2026-07-27T05:36:52.000Z thumbnail image

Stay in the know with updates to Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.